RNA therapy reverses pathological cardiac remodeling, improving heart function and prolonging life.
hypertrophic cardiomyopathy
Posted inCardiology, Metabolism, New Drugs, Regulatory
Camzyos: First Specific Drug to Treat Hypertrophic Cardiomyopathy
Mavacamten by Bristol-Myers Squibb is a new breath for all patients with obstructive hypertrophic cardiomyopathy.